Overview
- 9 inspections across 9 sites are on record.
- 32 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-10-04.
At a glance
Inspections
9
Sites
9
Observations
32
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| KREATIVE ACTIVES PRIVATE LIMITED | 4 Oct 2024 | Human Drugs | |
| Sun Pharmaceutical Industries Limited | 17 May 2024 | Human Drugs | On file |
| Cipla Limited | 8 May 2024 | Human Drugs | On file |
| Novartis d.o.o. | 9 Feb 2024 | Human Drugs | View 483 → |
| Glaxo Wellcome Manufacturing Pte. Ltd | 2 Sep 2022 | Human Drugs |
Sites inspected
KREATIVE ACTIVES PRIVATE LIMITEDAtchutapuram, Visakhapatnam, India1 insp.
Sun Pharmaceutical Industries LimitedBharuch, India1 insp.
Cipla LimitedKurkumbh Village, Dist. Pune, India1 insp.
Novartis d.o.o.Ljubljana, Slovenia1 insp.
Glaxo Wellcome Manufacturing Pte. LtdSingapore, Singapore1 insp.
Co-investigators
Investigators who share inspections with this person.
Santos E Camara2 shared
Jennifer L Huntington1 shared
Bijoy Panicker1 shared
Seneca D Toms1 shared
William J Leonard1 shared
Linda Thai1 shared
Jogy George1 shared
Frank Wackes1 shared
Helen Verdel1 shared
Full investigator report
Get the verbatim findings behind Haitao Li's 32 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site